BIT's 17th Annual Congress of International Drug Discovery Science & Technology-China 2019

● Designing 80+ Sessions of Scientific Forums, Symposia, Roundtables, Dialogs, Workshops and Training Courses
● Inviting Worldwide Distinguished Experts, Investors, and Decision Makers in the areas of Drug Discovery for the Grand Thought Collision from 50+ Countries
● Shooting for 400+ Oral Presentations and Hot Paper Briefing in whole Spectrum of Drug Discovery Fields
● Gathering 50+ Exhibitors in Cutting-edge Technologies and Novel Bioproducts
● Bringing in 20+ Professional Media Supporters
● Scheduling 5+ Sessions of Business & Career Development, and Talent Search
● Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and New Products

Keynote Speakers

Dr. Maode Lai,
Academician of Nationale Akademie der Wissenschafte,
President, China Pharmaceutical University,


Dr. Christopher Abell,
Fellow of the Royal Society, Pro-Vice-Chancellor for Research,
The University of Cambridge,

Dr. Ge Li,
WuXi AppTec Group,

Dr. Henrietta Ukwu,
Senior Vice President, Head of Global Regulatory Affairs,

Our Renowned Speakers
Dr. Richard Soll, Senior Vice President and Head of International Discovery Service Unit,WuXi AppTec, USA
Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System, University of California, Irvine, USA Dr. Litao Zhang, Vice President, Leads Discovery and Optimization, Bristol-Myers Squibb, USA
Dr. Jan Hoflack, Chief Scientific and Operational Officer, Oncodesign SA, France Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU, Medicine Development Center, Eisai Co., Ltd., Japan Dr. David C. Bunton, CEO, REPROCELL Europe Ltd., UK
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd., UK Dr. Chris H. Senanayake, Vice President, Boehringer Ingelheim Pharmaceuticals, Inc., USA Dr. Bruce Given, COO, Arrowhead Research Corporation, USA
说明: scientificprogram3_clip_image006.jpg Dr. Dieter Lubda, Head Actives Formulation RD Operations, Life Science | Process Solutions | Actives Formulation, Merck, Germany 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Qi Yin, Clinical Sciences Therapeutic Area Head, Cardiovascular and Metabolic Diseases, Novartis Institutes for BioMedical Research, USA Dr. Jeffery Liu, Director, GSK, USA
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Steffen Denzinger, Director, Strategy and Business Development Process Solutions, Merck Millipore, Germany Dr. Tina Tao, Head of APAC E2E Biodevelopment Center, Merck Group, China Dr. Eric Westhof, Academician, Vice President for Research and Doctoral Studies of the University of Strasbourg, France 
Dr. Cheng Zhang, Chief Scientific Officer, Gmax BioPharm, China Dr. Hong Ling, VP of Innovation, Head of Pipeline and Scientific Evaluation, Qilu Pharmaceuticals, China 说明: scientificprogram3_clip_image008.jpg Dr. Zhen Li, Senior Vice President, Chemistry and Non-Clinical Development, Arrowhead Pharmaceuticals, Inc., USA 
Dr. Emil Fu, Senior VP, International Integration, Fountain Medical Development, China 说明: scientificprogram4_clip_image063.jpg Dr. Jeffrey Hung, Chief Commercial Officer, GM of cGMP Business, Vigene Biosciences, Inc., USA Dr. Beat Flühmann 
Vifor Pharma Ltd
说明: Mingde-Xia.jpg Dr. Ghotas Evindar, Chemistry Group Leader, GlaxoSmithKline, USA 说明: scientificprogram4_clip_image045.jpg Dr. John Lambert, Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China 说明: scientificprogram3_clip_image030.jpg Dr. Gerald J. Yakatan, Chairman & CEO, IriSys, LLC,.USA
Dr. Rashida A.Karmali, CEO & President, Tactical Therapeutics, Inc., USA 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Wei Li, Professor and Director of UTCoP Drug Discovery Center, University of Tennessee Health Science Center, USA 说明: 说明: scientificprogram3_clip_image022.jpg  Dr. Weiyi Zhang, Director, External Innovation China Research Beyond Borders, Corporate Discovery Research, Boehringer-IngelheimPharma, China
说明: 说明: scientificprogram3_clip_image034.jpg Dr. Anthony W. Coleman, Research Director, University of Lyon, France
说明: 说明: scientificprogram3_clip_image016.jpg
Dr. Xinyuan Liu, Academician of Chinese Academy of Sciences, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, China 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Jing Li, Senior Vice President, Biologics Discovery, Wuxi Biologics, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Chris Vernall, Business Development Director, Intertek Melbourn, UK 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Robert Borris, Vice-Dean, School of Pharmaceutical Science and Technology, Tianjin University, China 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Thomas Saiying Ko, Chief Technical Officer, Biolingus Technology Development ( HK) P.L. - Part Of Biolingus IP GMBH, Switzerland
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Jinhua Wang, Principal Investigator, Institute of Medicine, Chinese Academy of Medical Sciences, China 说明: 说明: scientificprogram3_clip_image016.jpg Dr.Xingchun Gou, Professor, Xi'an Medical University, China 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Hakim Mohamed, President and CEO, Once Source Clinical & Management, USA
Dr. Rakesh Ranjan, Executive Medical Director, Charak Clinical Research Center, USA 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Chin-Tarng Lin, Professor, National Taiwan University Hospital, Taiwan 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Ole Winther Rasmussen, Associate Professor, Medical Department, Kolding Hospital, Denmark
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Guo-Ping Zhou, Adjunct Professor, Harvard Medical School, USA 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Wei Min Huang, Associate Professor, School of Mechanical and Aerospace Engineering, Nanyang Technological University, Singapore 说明: 说明: scientificprogram3_clip_image016.jpg Dr. Shengjun Zhang,Vice President and Chief Medical Officer, JOINN Laboratories, China
说明: 说明: scientificprogram3_clip_image016.jpg Dr. Jerry Thornthwaite, Director, Cancer Research Institute of West Tennessee, USA
Past Conference Report

On November 6-8, 2018, IDDST-China 2018 was held in Sheraton Jinan Hotel, China, achieved a consummation. The theme of this conference is “Focusing on Biomedical Frontiers, Driving Industrial Innovative Development". Almost 300 participants from over 30 countries and regions shared the details of their research during the sessions. It was sure to announce it gained a great success and obtained highly focus and extensive attention around the globe. We appreciate the contribution of all the speakers, who have conveyed their latest results in the conference.

...View more

Scenery of Nanjing

Nanjing is the capital of Jiangsu Province in East China, running through the city are lower reaches of the Yangtze River whose estuary is not far away. Nanjing enjoys a civilization of over 6000 years and the city itself was founded 2500 years ago. Enclosed by mountains and rivers, and located in a strategic place, it boasts picturesque scenery that blends natural landscape with towering modern buildings, integrating traditional styles with modern civilization. Thus it was known as a unique historic and cultural city to the world.
As one of the Four Ancient Capitals, Nanjing is a vital cradle of Chinese civilization and over a long stretch of time, it has been the political and cultural pivot of South China, thus dubbed as the Capital of Ten Ancient Dynasties, rich in both cultural heritage and historical relics. Among the landmarks of Nanjing there are the City Wall, the Ming Xiaoling Mausoleum, Dr. Sun Yat-sen Mausoleum, Presidential Palace and Confucius Temple.

Scenery of Nanjing

Program Release
Online Registration
News Release
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organization

Jiangsu Pharmaceutical Association

Operating Organizations

Information Research Center of International Talent, SAFEA

BIT Group Global Ltd.
Supporting Organization

Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China

Official Travel Agency
Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.